These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3509276)

  • 1. Bovine RPE heterotransplants simulate proliferative vitreoretinopathy (PVR) in rabbits.
    Weinsieder A; Radtke ND; Currier GJ; Caple S; Presley E; Weinsieder G
    Metab Pediatr Syst Ophthalmol (1985); 1987; 10(1):2-8. PubMed ID: 3509276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B; Sorgente N
    Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of experimental proliferative vitreoretinopathy in rabbits].
    Kuriyama S; Ohuchi T; Okada M; Yamakawa R; Yoshimura N; Honda Y
    Nippon Ganka Gakkai Zasshi; 1990 Sep; 94(9):792-8. PubMed ID: 2248164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
    Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.
    Stern WH; Lewis GP; Erickson PA; Guerin CJ; Anderson DH; Fisher SK; O'Donnell JJ
    Am J Ophthalmol; 1983 Jul; 96(1):33-42. PubMed ID: 6869478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
    Yang CM; Cousins SW
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2436-42. PubMed ID: 1634341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration.
    Campochiaro PA; Jerdan JA; Glaser BM; Cardin A; Michels RG
    Arch Ophthalmol; 1985 Sep; 103(9):1403-5. PubMed ID: 4038135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of drug treatments for proliferative vitreoretinopathy using vitreous microtensiometry.
    Moorhead LC; Sepahban S; Armeniades CD
    Ann Ophthalmol; 1991 Sep; 23(9):349-55. PubMed ID: 1741609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy.
    Sen HA; Robertson TJ; Conway BP; Campochiaro PA
    Arch Ophthalmol; 1988 Sep; 106(9):1291-4. PubMed ID: 3415556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative vitreoretinopathy in the Swine-a new model.
    Umazume K; Barak Y; McDonald K; Liu L; Kaplan HJ; Tamiya S
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4910-6. PubMed ID: 22729438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological therapy for proliferative vitreoretinopathy.
    Radtke ND; Weinsieder AD; Ballou RJ
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(3):230-3. PubMed ID: 3710177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
    Martini B
    Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panretinal photocoagulation aggravates experimental proliferative vitreoretinopathy.
    Algvere PV; Hallnäs K; Dafgård E; Höög A
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(5):461-6. PubMed ID: 2227493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture.
    Machemer R
    Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1771-83. PubMed ID: 3056866
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autotransplantation of the retinal pigment epithelium (RPE). A contribution on the MVR problem].
    Mueller-Jensen K; Machemer R
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1975; (73):422-6. PubMed ID: 1242956
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits.
    Yu HG; Chung H
    Korean J Ophthalmol; 1997 Dec; 11(2):98-105. PubMed ID: 9510652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
    Moritera T; Ogura Y; Yoshimura N; Honda Y; Wada R; Hyon SH; Ikada Y
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3125-30. PubMed ID: 1399416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryotherapy enhances intravitreal dispersion of viable retinal pigment epithelial cells.
    Campochiaro PA; Kaden IH; Vidaurri-Leal J; Glaser BM
    Arch Ophthalmol; 1985 Mar; 103(3):434-6. PubMed ID: 3977720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P; Heimann K; Bartz-schmidt KU; Fontana A; Schraermeyer U; Thumann G; Weller M
    Exp Eye Res; 1997 Sep; 65(3):365-78. PubMed ID: 9299173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
    Steinhorst UH; Chen EP; Machemer R; Hatchell DL
    Exp Eye Res; 1993 Apr; 56(4):489-95. PubMed ID: 8500561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.